Samsara BioCapital GP, 10% Owner: Mineralys Therapeutics MLYS Buy · Filed 24/02/14

Trade details

Type: Insider buy
Amount: $7,499,992.5
Shares · price: 555,555 sh · $13.50 a share
Held after: 5,074,916 sh
Stock: Mineralys Therapeutics MLYS
Person: Samsara BioCapital GP10% Owner
Trade date: 24/02/12
Filed: 24/02/14
Days to filing: 2 days

First buy since 2023

Insiders buying this week: 2 insiders
Holding change: +12.3%

Mineralys Therapeutics trades, last 26 weeks

What else happened in Mineralys Therapeutics around then

Filed or reported within 30 days of the trade day · 24/01/13~24/03/13

Samsara BioCapital GP's recent trades

Samsara BioCapital GP10% Owner
BuyKalaris Therapeutics
Buy
Kalaris Therapeutics
KLRS
$1.2M
244,300 sh
$1.2M
Filed 05/22
Traded 05/20
Samsara BioCapital GP10% Owner
BuyKalaris Therapeutics
Buy
Kalaris Therapeutics
KLRS
$5M
479,847 sh
$5M
Filed 02/17
Traded 25/12/18
Samsara BioCapital GP10% Owner
BuyMineralys Therapeutics
Buy
Mineralys Therapeutics
MLYS
$8.1M
600,000 sh
$8.1M
Filed 25/03/17
Traded 25/03/13
Samsara BioCapital GP10% Owner
BuyNeurogene
Buy
Neurogene
NGNE
$516.8K
20,748 sh
$516.8K
Filed 24/11/27
Traded 24/11/26
Samsara BioCapital GP10% Owner
BuyNeurogene
Buy
Neurogene
NGNE
$406.8K
15,219 sh
$406.8K
Filed 24/11/27
Traded 24/11/26